Wed 17'th Oct 2018
Innovate Biopharmaceuticals, Inc. Stock Analysis
Technical stock analysis for Wed 17'th Oct 2018
|Shorts||1.46% ( 2018-09-28 )|
Innovate Biopharmaceuticals, Inc. fell by -1.31% in the last day from $5.35 to $5.28 and has now fallen 3 days in a row. The price has fallen in 7 of the last 10 days and is down by -18.14% for this period. Volume has increased in the last day by 22 062 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 245 134 shares bought and sold for approximately $1.29 million.
Innovate Biopharmaceuticals, Inc. lies in the lower part of a very wide and weak rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $4.80 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 4.82% during the next 3 months and, with 90% probability hold a price between $5.03 and $9.61 at the end of this period.
There are few to none technical positive signals at the moment. Innovate Biopharmaceuticals, Inc. holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $5.32 and $6.29. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Monday October 15, 2018, which indicates further falls until a new bottom pivot has been found. Innovate Biopharmaceuticals, Inc. gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".
Relative Strength Index (RSI)
The stock currently holds a RSI14 at 19 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.
Support & Resistance
Innovate Biopharmaceuticals, Inc. finds support from accumulated volume at $5.22.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.29 between high and low, or 5.65%. For the last week, the stock has had a daily average volatility of 8.67%.
Innovate Biopharmaceuticals, Inc. is oversold on RSI14 (19). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
The Innovate Biopharmaceuticals, Inc. stock holds several negative signals and despite the positive trend we believe Innovate Biopharmaceuticals, Inc. will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.Click for Top 5 Sell Candidates
|Get a PRO membership|
To Reveal Top 5 Sell Candidates
Follow Auto Portfolios gaining up to 30%.
Disclaimer: There is no guarantee against any loss. Your capital is at risk.
Click to become a PRO member